Sharing patient-level data from clinical trials can improve the quality of research, but there are concerns about data sharing, and multiple different systems are being created. GSK was a first mover in making anonymized patient level data available from clinical trials. Dr. Perry Nisen, currently CEO of Sanford Prebys Medical Discovery Institute and formerly at GlaxoSmithKline, helped to establish GSK’s data sharing system in 2013. The site is now managed by the Wellcome Trust. (The New England Journal of Medicine)
Looking Beyond Risk in Risk-Based Monitoring
Data Sharing at a Crossroads: CEO of Sanford Burnham Prebys Medical Discovery Institute speaks out
A road map for 21st century drug discovery.
A Road Map for 21st Century Drug Discovery. Bioinformatics and Computational Biology in Drug Discovery and Development William Loging, editor Cambridge University Press, 2016 Review by Mary Chitty, Library Director & Taxonomist, Cambridge Healthtech Institute
Digital best practices for accelerating drug development
Many Americans Have Reservations About Clinical Trials
Just four in 10 Americans have a positive impression of clinical trials, and only about one-third of Americans would be likely to enroll in one, according to a study commissioned by the Memorial Sloan Kettering Cancer Center in New York City…
More than half (55 percent) of those surveyed were worried about side effects and safety. Half were concerned about insurance coverage and out-of-pocket costs. Nearly half (48 percent) were concerned about the inconvenience of trial locations, or receiving a placebo instead of an active treatment drug (46 percent). Additionally, 35 percent of those surveyed expressed skepticism about unproven treatments, while 34 percent said a clinical trial would make them feel like a guinea pig. (doctorslounge.com)
CISCRP unveils the results of the 2015 Perceptions & Insights Study
Trends in global clinical trial registration
The number of clinical trials registered globally increased from 3,294 in 2004 to 23,384 in 2013, according to new research published in BMJ Open. (AllTrials)
Pressure group floats idea of government-backed clinical trial awareness campaign
The Coalition for Clinical Trials Awareness (CCTA) has called for a federally-supported public health campaign to make people more aware of drug research and the value of participating in studies. (Outsourcing-Pharma.com)